105 related articles for article (PubMed ID: 23053021)
21. Protein kinase A mediates scopolamine-induced mTOR activation and an antidepressant response.
Dong J; Zhou Q; Wei Z; Yan S; Sun F; Cai X
J Affect Disord; 2018 Feb; 227():633-642. PubMed ID: 29174736
[TBL] [Abstract][Full Text] [Related]
22. Griflola frondosa (GF) produces significant antidepressant effects involving AMPA receptor activation in mice.
Bao H; Ran P; Sun L; Hu W; Li H; Xiao C; Zhu K; Du J
Pharm Biol; 2017 Dec; 55(1):299-305. PubMed ID: 27937670
[TBL] [Abstract][Full Text] [Related]
23. Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test.
Wang X; Yang Y; Zhou X; Wu J; Li J; Jiang X; Qu Q; Ou C; Liu L; Zhou S
Psychiatry Res; 2011 Jan; 185(1-2):248-53. PubMed ID: 20580983
[TBL] [Abstract][Full Text] [Related]
24. α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor activation protects against phencyclidine-induced caspase-3 activity by activating voltage-gated calcium channels.
Timpe JM; Wang CZ; Kim J; Johnson KM
J Neurosci Res; 2014 Dec; 92(12):1785-91. PubMed ID: 24995437
[TBL] [Abstract][Full Text] [Related]
25. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
Koike H; Chaki S
Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
[TBL] [Abstract][Full Text] [Related]
26. Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc.
Szewczyk B; Pochwat B; Rafało A; Palucha-Poniewiera A; Domin H; Nowak G
Neuropharmacology; 2015 Dec; 99():517-26. PubMed ID: 26297535
[TBL] [Abstract][Full Text] [Related]
27. Total Saikosaponins of Bupleurum yinchowense reduces depressive, anxiety-like behavior and increases synaptic proteins expression in chronic corticosterine-treated mice.
Sun X; Li X; Pan R; Xu Y; Wang Q; Song M
BMC Complement Altern Med; 2018 Apr; 18(1):117. PubMed ID: 29609584
[TBL] [Abstract][Full Text] [Related]
28. Stargazin Modulation of AMPA Receptors.
Shaikh SA; Dolino DM; Lee G; Chatterjee S; MacLean DM; Flatebo C; Landes CF; Jayaraman V
Cell Rep; 2016 Oct; 17(2):328-335. PubMed ID: 27705782
[TBL] [Abstract][Full Text] [Related]
29. Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling.
Neis VB; Moretti M; Bettio LE; Ribeiro CM; Rosa PB; Gonçalves FM; Lopes MW; Leal RB; Rodrigues AL
Eur Neuropsychopharmacol; 2016 Jun; 26(6):959-71. PubMed ID: 27061850
[TBL] [Abstract][Full Text] [Related]
30. Lead-Induced ERK Activation Is Mediated by GluR2 Non-containing AMPA Receptor in Cortical Neurons.
Ishida K; Kotake Y; Sanoh S; Ohta S
Biol Pharm Bull; 2017; 40(3):303-309. PubMed ID: 28250271
[TBL] [Abstract][Full Text] [Related]
31. The AMPA receptor potentiator Org 26576 modulates stress-induced transcription of BDNF isoforms in rat hippocampus.
Fumagalli F; Calabrese F; Luoni A; Shahid M; Racagni G; Riva MA
Pharmacol Res; 2012 Feb; 65(2):176-81. PubMed ID: 22079295
[TBL] [Abstract][Full Text] [Related]
32. The pharmacology of AMPA receptors and their antagonists.
Sheardown MJ
Stroke; 1993 Dec; 24(12 Suppl):I146-7; discussion I153-4. PubMed ID: 7504337
[No Abstract] [Full Text] [Related]
33. Mercuric chloride modulates [3H]AMPA binding to Xenopus brain membranes.
Henley JM; Kirkham DM
Biochem Soc Trans; 1995 Feb; 23(1):118S. PubMed ID: 7538941
[No Abstract] [Full Text] [Related]
34. AMPA receptor potentiators as novel antidepressants.
Alt A; Witkin JM; Bleakman D
Curr Pharm Des; 2005; 11(12):1511-27. PubMed ID: 15892659
[TBL] [Abstract][Full Text] [Related]
35. Behavioral, neurochemical and molecular changes after acute deep brain stimulation of the infralimbic prefrontal cortex.
Jiménez-Sánchez L; Linge R; Campa L; Valdizán EM; Pazos Á; Díaz Á; Adell A
Neuropharmacology; 2016 Sep; 108():91-102. PubMed ID: 27108934
[TBL] [Abstract][Full Text] [Related]
36. Piper sarmentosum Roxb. produces antidepressant-like effects in rodents, associated with activation of the CREB-BDNF-ERK signaling pathway and reversal of HPA axis hyperactivity.
Li Q; Qu FL; Gao Y; Jiang YP; Rahman K; Lee KH; Han T; Qin LP
J Ethnopharmacol; 2017 Mar; 199():9-19. PubMed ID: 28126450
[TBL] [Abstract][Full Text] [Related]
37. AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression.
Wu X; Zhu D; Jiang X; Okagaki P; Mearow K; Zhu G; McCall S; Banaudha K; Lipsky RH; Marini AM
J Neurochem; 2004 Aug; 90(4):807-18. PubMed ID: 15287886
[TBL] [Abstract][Full Text] [Related]
38. Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial.
Nations KR; Dogterom P; Bursi R; Schipper J; Greenwald S; Zraket D; Gertsik L; Johnstone J; Lee A; Pande Y; Ruigt G; Ereshefsky L
J Psychopharmacol; 2012 Dec; 26(12):1525-39. PubMed ID: 22954616
[TBL] [Abstract][Full Text] [Related]
39. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
Koike H; Iijima M; Chaki S
Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
[TBL] [Abstract][Full Text] [Related]
40. Antidepressant Effects of Pharmacopuncture on Behavior and Brain-Derived Neurotrophic Factor (BDNF) Expression in Chronic Stress Model of Mice.
Kim Y; Lee HY; Cho SH
J Acupunct Meridian Stud; 2017 Dec; 10(6):402-408. PubMed ID: 29275796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
